BBLG

Bone Biologics

8 hedge funds and large institutions have $235K invested in Bone Biologics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.

Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Walleye Capital
1
Walleye Capital
New York
$192K 270,199 -24,801 -8%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$11.4K 16,013 +16,013 New
MML Investors Services
3
MML Investors Services
Massachusetts
$11K 15,000 +15,000 New
Citadel Advisors
4
Citadel Advisors
Florida
$8.05K 11,335 +11,335 New
VF
5
Virtu Financial
New York
$8K 11,248 -4,684 -29%
TRCT
6
Tower Research Capital (TRC)
New York
$4.75K 6,687 +646 +11%
UBS Group
7
UBS Group
Switzerland
$96 135 +135 New
Wells Fargo
8
Wells Fargo
California
$16 23 +21 +1,050%
KC
9
Kepos Capital
New York
-50,000 Closed
WAM
10
Warberg Asset Management
Illinois
-27,000 Closed
SM
11
Sabby Management
Florida
-10,817 Closed
CFGS
12
Concourse Financial Group Securities
Alabama